Decrease of serum S100B during an oral glucose tolerance test correlates inversely with the insulin response

Psychoneuroendocrinology

Volumn 39, Issue 1, 2014, Pages 33-38

  Steiner, Johann ^a,b   Bernstein, Hans Gert ^a   Schiltz, Kolja ^a,b   Haase, Thekla ^a   Meyer Lotz, Gabriela ^a   Dobrowolny, Henrik ^a   Müller, Ulf J ^a   Martins de Souza, Daniel ^a,c   Borucki, Katrin ^a   Schroeter, Matthias L ^d,e   Isermann, Berend ^a   Bogerts, Bernhard ^a,b   Westphal, Sabine ^a,f  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Center for Behavioral Brain Science (CBBS)   (Germany)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f Dessau Hospital   (Germany)

Author keywords

Adipocytes; Astrocytes; Hepatocytes; Insulin; Oligodendrocytes; Oral glucose tolerance; S100B

Indexed keywords

C PEPTIDE; FATTY ACID; GLUCOSE; HYDROCORTISONE; INSULIN; PROTEIN S100B;

ADIPOCYTE; ADULT; ARTICLE; CELLULAR DISTRIBUTION; CELLULAR SECRETION; DIET RESTRICTION; DOWN REGULATION; FATTY ACID BLOOD LEVEL; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESPONSE; LIVER BIOPSY; LIVER CELL; MALE; NEWBORN; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STRESS; SUBCUTANEOUS FAT; UPREGULATION; CHILD; IMMUNOREACTIVITY; IN VIVO STUDY; PROTEIN SECRETION;

ADIPOCYTES; ASTROCYTES; HEPATOCYTES; INSULIN; OLIGODENDROCYTES; ORAL GLUCOSE TOLERANCE; S100B;

ADULT; BLOOD GLUCOSE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT;

EID: 84888044357     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.10.001     Document Type: Article

References (20)

1. Donato R., Sorci G., Riuzzi F., Arcuri C., Bianchi R., Brozzi F., Tubaro C., Giambanco I. S100B's double life: intracellular regulator and extracellular signal. Biochim. Biophys. Acta 2009, 1793:1008-1022.
2. Goncalves C.A., Leite M.C., Guerra M.C. Adipocytes as an important source of serum S100B and possible roles of this protein in adipose tissue. Cardiovasc. Psychiatr. Neurol. 2010, 10.1155/2010/790431.
3. Marchi N., Cavaglia M., Fazio V., Bhudia S., Hallene K., Janigro D. Peripheral markers of blood-brain barrier damage. Clin. Chim. Acta 2004, 342:1-12.
4. Moore B.W. A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 1965, 19:739-744.
5. Morera-Fumero A.L., Abreu-Gonzalez P., Henry-Benitez M., Yelmo-Cruz S., Diaz-Mesa E. Summer/winter changes in serum S100B protein concentration as a source of research variance. J. Psychiatr. Res. 2013, 47:791-795.
6. Nardin P., Tramontina F., Leite M.C., Tramontina A.C., Quincozes-Santos A., de Almeida L.M., Battastini A.M., Gottfried C., Goncalves C.A. S100B content and secretion decrease in astrocytes cultured in high-glucose medium. Neurochem. Int. 2007, 50:774-782.
7. Netto C.B., Conte S., Leite M.C., Pires C., Martins T.L., Vidal P., Benfato M.S., Giugliani R., Goncalves C.A. Serum S100B protein is increased in fasting rats. Arch. Med. Res. 2006, 37:683-686.
8. Pelinka L.E., Harada N., Szalay L., Jafarmadar M., Redl H., Bahrami S. Release of S100B differs during ischemia and reperfusion of the liver, the gut, and the kidney in rats. Shock 2004, 21:72-76.
9. Pham N., Fazio V., Cucullo L., Teng Q., Biberthaler P., Bazarian J.J., Janigro D. Extracranial sources of S100B do not affect serum levels. PLoS ONE 2010, 10.1371/journal.pone.0012691.
10. Rendell M. The expanding clinical use of C-peptide radioimmunoassay. Acta Diabetol. Lat. 1983, 20:105-113.
11. Rothermundt M., Peters M., Prehn J.H., Arolt V. S100B in brain damage and neurodegeneration. Microsc. Res. Tech. 2003, 60:614-632.
12. Scaccianoce S., Del Bianco P., Pannitteri G., Passarelli F. Relationship between stress and circulating levels of S100B protein. Brain Res. 2004, 1004:208-211.
13. Schroeter M.L., Steiner J. Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders. Mol. Psychiatr. 2009, 14:235-237.
14. Steiner J., Bernstein H.G., Bielau H., Berndt A., Brisch R., Mawrin C., Keilhoff G., Bogerts B. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci. 2007, 10.1186/1471-2202-8-2.
15. Steiner J., Bernstein H.G., Bogerts B., Gos T., Richter-Landsberg C., Wunderlich M.T., Keilhoff G. S100B is expressed in, and released from, OLN-93 oligodendrocytes: Influence of serum and glucose deprivation. Neuroscience 2008, 154:496-503.
16. Steiner J., Schiltz K., Walter M., Wunderlich M.T., Keilhoff G., Brisch R., Bielau H., Bernstein H.G., Bogerts B., Schroeter M.L., Westphal S. S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research. Psychoneuroendocrinology 2010, 35:321-324.
17. Suzuki F., Kato K. Inhibition of adipose S-100 protein release by insulin. Biochim. Biophys. Acta 1985, 845:311-316.
18. Thaler J.P., Yi C.X., Schur E.A., Guyenet S.J., Hwang B.H., Dietrich M.O., Zhao X., Sarruf D.A., Izgur V., Maravilla K.R., Nguyen H.T., Fischer J.D., Matsen M.E., Wisse B.E., Morton G.J., Horvath T.L., Baskin D.G., Tschop M.H., Schwartz M.W. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 2012, 122:153-162.
19. Yamashita M., Qian Z.R., Sano T., Horvath E., Kovacs K. Immunohistochemical study on so-called follicular cells and folliculostellate cells in the human adenohypophysis. Pathol. Int. 2005, 55:244-247.
20. Zimmer D.B., Chessher J., Wilson G.L., Zimmer W.E. S100A1 and S100B expression and target proteins in type I diabetes. Endocrinology 1997, 138:5176-5183.